The pediatric-modified total neuropathy score: A reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers

Supportive Care in Cancer

Volumn 21, Issue 3, 2013, Pages 847-856

  Gilchrist, Laura S ^a,b   Tanner, Lynn ^a  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b ST CATHERINE UNIVERSITY   (United States)

Author keywords

Cancer; Chemotherapy; Neuropathy; Pediatrics

Indexed keywords

CISPLATIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BODY EQUILIBRIUM; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HAND FUNCTION; HUMAN; INTERRATER RELIABILITY; LIVER CANCER; LYMPHOMA; MALE; MUSCLE CANCER; NEPHROBLASTOMA; OVARY CANCER; PEDIATRIC MODIFIED TOTAL NEUROPATHY SCALE; PERIPHERAL NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SOLID TUMOR; TEST RETEST RELIABILITY; VALIDITY;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEOPLASMS; NEUROTOXICITY SYNDROMES; OBSERVER VARIATION; PERIPHERAL NERVOUS SYSTEM DISEASES; REPRODUCIBILITY OF RESULTS;

EID: 84874116179     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1591-8     Document Type: Article

References (22)

1. Ries LAG, Smith MA, Gurney JG, et al. (eds) (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD
2. Markman M (2006) Chemotherapy-induced peripheral neuropathy: underreported and underappreciated. Curr Pain Headache Rep 10:275-278
3. Cornblath DR, Chaudhry V, Carter MS et al (1999) Total Neuropathy Scale: validation and reliability study. Neurology 53:1660-1664
4. Cavaletti G, Bogliun G, Marzorati L et al (2003) Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale. Neurology 61:1297-1300
5. Cavaletti G, Jann S, Pace A et al (2006) Multi-center assessment of the Total Neuropathy Scale for chemotherapy-induced peripheral neurotoxicity. J Periph Nerv Syst 11:135-141
6. Wampler MA, Miaskowski C, Hamel K et al (2006) The modified total neuropathy score: a clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. J Support Oncol 4:9-16
7. Wright MJ, Galea V, Barr RD (2005) Proficiency of balance in children and youth who have had acute lymphoblastic leukemia. Phys Ther 85:782-790
8. Hartman A, van den Bos C, Stijnen T, Pieters R (2009) Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine. Cancer 106:1395-1401
9. Gilchrist LS, Tanner L, Hooke MC (2009) Measuring chemotherapy-induced peripheral neuropathy in children: development of the Ped-mTNS and pilot study results. Rehabil Oncol 27:7-15
10. Bruininks RH, Bruininks BD (2005) BOT-2: Bruininks-Oseretsky test of motor proficiency, 2nd edn. Pearson Assessments, Minneapolis
11. Bell JA (1984) Semmes-Weinstein monofilament testing for determining cutaneous light touch/deep pressure sensation. Star 44:8-11
12. Hilz MJ, Axelrod FB, Hermann K, Haertl U et al (1998) Normative values of vibratory perception in 530 children, juveniles, and adults aged 3-79 years. J Neurolog Sci 159:219-225
13. Coutinho dos Santos LH, Bruck I, Antoniuk SA, Sandrini R (2002) Evaluation of sensorimotor polyneuropathy in children and adolescents with type I diabetes: association with microalbuminuria and retinopathy. Pediatric Diabetes 3:101-108
14. Medical Research Council of the United Kingdom (1978) Aids to examination of the peripheral nervous system: memorandum no 45. Pedragon House, Palo Alto
15. Dick JPR (2003) The deep tendon and the abdominal reflexes. J Neurol Neurosurg Psychaitry 74:150-153
16. Dietz JC, Kartin D, Kopp K (2007) Review of the Bruininks-Oseretsky test of motor proficiency, second edition (BOT-2). Phys Occup Ther Pediatr 27:87-102
17. Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press, New York
18. DCTD, NCI, NIH, DHHS (2010) Cancer Therapy evaluation program, common terminology criteria for adverse events, Version 4.03. http://evs.nci.nih.gov/ ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7.pdf. Published June 14, 2010. Accessed 23 January 2011
19. Postma TJ, Heimans JJ, Muller MJ et al (1998) Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy. Ann Oncol 9:739-744
20. Lavoie Smith E, Cohen JA, Pett MA, Beck SL (2010) The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Cancer Nurs 33:173-183
21. Ramchandren S, Leonard M, Mody RJ et al (2009) Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia. J Periph Nerv Syst 14:184-189
22. DeVellis RF (2003) Scale development: theory and application, 2nd edn. SAGE, Thousand Oaks